Monthwise SARS CoV-2 mutation statistics
Position | Mutation | Clade |
---|---|---|
82 | nsp12:H82-; | CL-3b;CL-3f; |
82 | nsp12:H82Y; | CL-1a;CL-2;CL-3b;CL-3d;CL-3e;CL-3f; |
872 | nsp12:H872Y; | CL-1b; |
882 | nsp12:H882-; | CL-3b;CL-3d;CL-3f; |
892 | nsp12:H892Y; | CL-3b;CL-3c;CL-3e;CL-5; |
928 | nsp12:H928-; | CL-3e;CL-3f; |
928 | nsp12:H928Q; | CL-3e; |
106 | nsp12:I106M; | CL-3d;CL-3f; |
114 | nsp12:I114-; | CL-3e; |
114 | nsp12:I114M; | CL-2; |
114 | nsp12:I114R; | CL-5; |
145 | nsp12:I145L; | CL-3e; |
145 | nsp12:I145M; | CL-1b; |
171 | nsp12:I171M; | CL-2;CL-3e; |
171 | nsp12:I171V; | CL-3b; |
201 | nsp12:I201L; | CL-3b; |
244 | nsp12:I244M; | CL-5; |
244 | nsp12:I244V; | CL-3e; |
266 | nsp12:I266S; | CL-3b; |
266 | nsp12:I266V; | CL-3d; |
333 | nsp12:I333-; | CL-3f; |
333 | nsp12:I333M; | CL-3e; |
333 | nsp12:I333T; | CL-3d;CL-3f; |
37 | nsp12:I37V; | CL-3b; |
450 | nsp12:I450T; | CL-3e; |
450 | nsp12:I450V; | CL-1a_3e;CL-3c;CL-3d;CL-3e; |
466 | nsp12:I466-; | CL-3e; |
466 | nsp12:I466V; | CL-2;CL-3b;CL-3c;CL-3d;CL-3e; |
494 | nsp12:I494V; | CL-3e; |
536 | nsp12:I536V; | CL-3e; |
539 | nsp12:I539-; | CL-3b; |
539 | nsp12:I539T; | CL-3f; |
548 | nsp12:I548V; | CL-3d;CL-3e;CL-3f; |
562 | nsp12:I562V; | CL-3b;CL-3e; |
579 | nsp12:I579M; | CL-3c;CL-3e; |
579 | nsp12:I579V; | CL-3b;CL-3d; |
632 | nsp12:I632-; | CL-3b; |
632 | nsp12:I632T; | CL-3f; |
632 | nsp12:I632V; | CL-3d;CL-3e;CL-3f; |
66 | nsp12:I66S; | CL-1a_3e; |
66 | nsp12:I66V; | CL-3e; |
757 | nsp12:I757-; | CL-3e; |
757 | nsp12:I757V; | CL-3b; |
779 | nsp12:I779V; | CL-3e; |
837 | nsp12:I837-; | CL-3b; |
837 | nsp12:I837V; | CL-3d; |
847 | nsp12:I847-; | CL-3d; |
847 | nsp12:I847V; | CL-1a;CL-3b;CL-3d; |
856 | nsp12:I856V; | CL-3e; |
864 | nsp12:I864-; | CL-5; |
Page 162 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com